NATASHYA ADAMS: Open Payments
NPI 1063979110 · OROVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,121 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $88 · 2025 $1,121
Food & beverage: $1,070Education: $51
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $220 |
| Janssen Biotech, Inc. | 2 | $193 |
| Boston Scientific Corporation | 1 | $183 |
| Madrigal Pharmaceuticals | 1 | $142 |
| GENZYME CORPORATION | 1 | $142 |
| ABBVIE INC. | 1 | $119 |
| PFIZER INC. | 1 | $83 |
| Janssen Scientific Affairs, LLC | 1 | $39 |
Products named: ENTYVIO, TREMFYA, Axios, REZDIFFRA, DUPIXENT, RINVOQ, VELSIPITY.
Industry payments across CA — which companies pay providers there.
